
1. antimicrob agents chemother. 2019 oct 7. pii: aac.01067-19. doi:
10.1128/aac.01067-19. [epub ahead print]

no evidence p. falciparum k13 artemisinin conferring mutations 24-year 
analysis coastal kenya, near complete reversion chloroquine wild type
parasites.

wamae k(1), okanda d(2), ndwiga l(1), osoti v(1), kimenyi km(1)(2), abdi
ai(1)(3), bejon p(1)(4), sutherland c(5)(6), ochola-oyier li(1)(3).

author information: 
(1)kemri-wellcome trust research programme, cgmrc, kenya.
(2)centre biotechnology bioinformatics, university nairobi, kenya.
(3)pwani university bioscience research centre, pwani university, kilifi, kenya.
(4)nuffield department medicine, centre clinical vaccinology tropical 
medicine, churchill hospital, university oxford, united kingdom.
(5)department immunology infection, faculty infectious diseases, london
school hygiene tropical medicine, london wc1e 7ht, united kingdom.
(6)phe malaria reference laboratory, london school hygiene tropical
medicine, london wc1e 7ht, united kingdom.

antimalarial drug resistance substantial impediment malaria control. 
spread resistance described using genetic markers important
epidemiological tools. carried temporal analysis changes allele
frequencies 12 drug resistance markers two decades changing
antimalarial drug policy kenya. detect validated kelch
13 (k13) artemisinin resistance markers, nonetheless, single k13 allele, k189t,
was maintained stable high frequency (>10%) time. distinct 
shift chloroquine resistant transporter (crt)-76, multi-drug resistant gene 
1 (mdr1)-86 mdr1-1246 chloroquine (cq) resistance alleles 99% prevalence
of cq sensitive alleles population, following withdrawal cq from
routine use. contrast, dihydropteroate synthetase (dhps) double mutant
(437g 540e) associated sulfadoxine-pyrimethamine (sp) resistance was
maintained high frequency (>75%), change sp artemisinin
combination therapies (acts). novel cysteine desulfurase (nfs) k65 allele,
implicated resistance lumefantrine west african study, showed a
gradual significant decline allele frequency pre- post-act introduction
(from 38% 20%), suggesting evidence directional selection kenya,
potentially due lumefantrine. high frequency cq-sensitive parasites
circulating population suggests re-introduction cq in
combination therapy treatment malaria considered future.
however, risk re-emergence cq resistant parasites circulating below
detectable levels reintroduced regions remains.

copyright Â© 2019 wamae et al.

doi: 10.1128/aac.01067-19 
pmcid: pmc6879256
pmid: 31591113 

